Core Viewpoint - Kanglong Chemical announced the approval of a capital increase and amendments to its articles of association during the shareholder meetings held on June 20, 2025 [1] Group 1 - The company completed the necessary business registration changes and obtained a new business license from the Beijing Economic and Technological Development Zone Market Supervision Administration [1]

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Pharmaron Beijing Co., Ltd. 康 龍 化 成（ 北 京 ）新 藥 技 術 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：3759） 海外監管公告 本公告乃康龍化成（北京）新藥技術股份有限公司（「本公司」）根據香港聯合交易所 有限公司證券上市規則第13.10B條作出。 茲載列本公司於深圳證券交易所網站刊登公告如下，僅供參閱。 承董事會命 康龍化成（北京）新藥技術股份有限公司 主席 樓柏良博士 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 康龙化成（北京）新药技术股份有限公司（以下简称"公司"）于 2025 年 6 月 20 日召开的 2024 年年度股东大会、2025 年第一次 A 股类别股东大会及 2025 年第一次 H 股类别股东大会审议通 ...

近日，公司办理完成相关内容的工商变更登记手续，并取得了北京经济技术 开发区市场监督管理局换发的《营业执照》。公司新换发的《营业执照》基本信 息如下： 统一社会信用代码：9111030276350109XG 康龙化成（北京）新药技术股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 康龙化成（北京）新药技术股份有限公司（以下简称"公司"）于 2025 年 6 月 20 日召开的 2024 年年度股东大会、2025 年第一次 A 股类别股东大会及 2025 年第一次 H 股类别股东大会审议通过了《关于增加注册资本、修订<公司章程> 的议案》。具体内容详见公司于 2025 年 3 月 27 日披露在巨潮资讯网 （www.cninfo.com.cn）的《关于注册资本增加、修订<公司章程>的公告》（公告 编号：2025-017）。 证券代码：300759 证券简称：康龙化成 公告编号：2025-040 名称：康龙化成（北京）新药技术股份有限公司 类型：股份有限公司（港澳台投资、上市） 法定代表人：楼柏良 注册资本：人民 ...

医药外包概念、生物医药、创新药等板块纷纷下滑。凯莱英（06821.HK）跌11.58%，康龙化成 （03759.HK）跌3.77%，和黄医药（00013.HK）跌15.99%，再鼎医药（09688.HK）跌10.47%，百济神 州（06160.HK）跌6.14%。 脑机接口概念股也表现不佳，南京熊猫电子股份（00553.HK）跌10.4%，心玮医疗-B（06609.HK）跌 5.68%，微创脑科学（02172.HK）跌3.47%。 8月8日，港股三大指数集体回调。其中，恒生指数跌0.89%，国企指数跌0.96%，恒生科技指数跌 1.56%。 分板块看，芯片、机器人概念等板块普遍回调。中芯国际（00981.HK）绩后跌8.19%，优必选 （09880.HK）跌5.06%，微创机器人-B（02252.HK）跌3.46%，贝克微（02149.HK）跌3.43%，上海复 旦（01385.HK）跌2.87%。 消息面，中芯国际 Q2营收同比增长16.2%，环比下降1.7%；净利润同比下降19%，不及市场预期，Q3 指引较为谨慎。此外，8月8日至12日，2025年世界机器人大会在北京盛大举行。分析称，这场备受瞩目 的产业 ...

Summary of Key Points Core Viewpoint - The 2024 A-share Secretary Data Report indicates that the total salary of A-share listed company secretaries reached 4.086 billion yuan, with an average annual salary of 754,300 yuan, highlighting the significant role of secretaries in connecting investors and listed companies [1][2]. Group 1: Overall Salary and Demographics - The total salary for A-share listed company secretaries in 2024 is 4.086 billion yuan, with an average annual salary of 754,300 yuan [1]. - Among the secretaries, those aged 40 and below constitute 43% of the market, while those aged 50 and above account for 22% [1]. - The educational background of secretaries shows that 34% hold a bachelor's degree, 52% have a master's degree, and 14% possess a doctoral degree [1]. Group 2: Industry-Specific Salary Insights - The average annual salary for secretaries in the pharmaceutical and medical service sector is 839,200 yuan [2]. - The distribution of salaries shows that 24% earn below 500,000 yuan, 48% earn between 500,000 and 1 million yuan, and 28% earn above 1 million yuan [2]. - The top three highest-paid secretaries are Gilbert Shing Chung Li from Kanglong Chemical with 1.9855 million yuan, Gao Dapeng from Zhaoyan New Drug with 1.7384 million yuan, and Xu Xiangke from Kailaiying with 1.6114 million yuan [2].

专题：专题|2024年度A股董秘数据报告：1144位董秘年薪超百万 占比超21% 责任编辑：公司观察 从薪酬分布看，A股医药医疗服务公司董秘年薪平均值为83.92万元。经统计，处于50万以下、50万-100 万、100万以上各区间的人数占比分别为24%、48%、28%。 其中，年薪排行前三的董秘分别为康龙化成的Gilbert Shing Chung Li（李承宗）、昭衍新药的高大鹏、 凯莱英的徐向科，三人年薪分别为198.55万元、173.84万元、161.14万元。 从薪酬变动幅度看，海特生物的杨坤2024年薪酬降幅最大，同比降幅达78.96%；何氏眼科的周晋峰薪 酬增幅最大，同比涨幅达142.8%。 分行业来看，统计数据显示，剔除董秘已离任公司后，A股共有50家上市医疗服务公司，其聘任总体情 况如下（部分统计口径剔除无效数据）。 从董秘的年龄分布来看，40岁及以下的董秘是市场的中坚力量，占比共计达到43%；50岁以上的董秘占 比为22%；40岁-50岁的董秘群体占比为35%。其中，目前仍任职的最年轻的男上市公司董秘年龄32岁， 为盈康生命的刘泽霖；最年轻的女董秘年龄为32岁，为创新医疗的郭立丹。 从董秘的 ...

Core Insights - The report highlights that in 2024, the total salary of A-share listed company secretaries reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - A total of 1,144 company secretaries earned over 1 million yuan, accounting for more than 21% of the total [1] Salary Distribution - The average annual salary for company secretaries in the medical and healthcare services sector is 839,200 yuan [2] - The distribution of salaries shows that 24% earn below 500,000 yuan, 48% earn between 500,000 and 1 million yuan, and 28% earn above 1 million yuan [2] - The top three highest-paid company secretaries are Gilbert Shing Chung Li from Kanglong Chemical with 1.9855 million yuan, Gao Dapeng from Zhaoyan New Drug with 1.7384 million yuan, and Xu Xiangke from Kailaiying with 1.6114 million yuan [2] Age and Education Distribution - Company secretaries aged 40 and below constitute 43% of the market, while those aged 50 and above account for 22% [1] - The educational background of company secretaries shows that 34% hold a bachelor's degree, 52% have a master's degree, and 14% possess a doctoral degree [1] - Among the doctoral degree holders, there are 7 individuals, with the only full-time doctoral company secretary in the industry being Cao Nai'en from Huaxia Eye Hospital [1]

来源：金融界 金融界2025年8月7日消息，中欧医疗健康混合A(003095) 最新净值1.9247元，下跌2.13%。该基金近1个 月收益率12.28%，同类排名748|4409；近6个月收益率24.19%，同类排名493|4271；今年来收益率 22.69%，同类排名997|4244。 中欧医疗健康混合A股票持仓前十占比合计54.73%，分别为：药明康德（10.39%）、恒瑞医药 （9.69%）、康龙化成（5.05%）、科伦药业（4.97%）、泰格医药（4.78%）、凯莱英（4.67%）、百利 天恒（4.11%）、信立泰（4.02%）、百济神州-U（3.66%）、新诺威（3.39%）。 公开资料显示，中欧医疗健康混合A基金成立于2016年9月29日，截至2025年6月30日，中欧医疗健康混 合A规模156.38亿元，基金经理为葛兰、赵磊。 简历显示：葛兰女士:中国籍。美国西北大学生物医学工程专业博士。历任国金证券股份有限公司研究 所研究员,民生加银基金管理有限公司研究员。2014年10月加入中欧基金管理有限公司,曾任研究员、中 欧明睿新起点灵活配置混合型证券投资基金基金经理(2015年1月29日起至201 ...

Group 1 - The stock price of Kanglong Chemical is reported at 28.90 yuan, down 1.83% from the previous trading day, with a trading volume of 1.184 billion yuan [1] - The company operates in the medical services sector as a CRO (Contract Research Organization), providing drug research and development services across various fields including laboratory chemistry, biological sciences, and clinical research services [1] - On August 7, the company stated on an interactive platform that the impact of the US tariffs on its business is limited, as the export of commercial goods constitutes a small portion of its operations [1] Group 2 - On August 7, the net outflow of main funds was 159 million yuan, with a cumulative net outflow of 471 million yuan over the past five trading days [2]

Group 1 - Jining Lightweight Auto Parts (Xi'an) Co., Ltd. has achieved an annual production capacity of 12 million steel plate blanks and 4 million hot-stamped parts, becoming a key supplier in Shaanxi's hot-stamping component industry [1] - The Xi'an Airport New City is focusing on building a modern airport industry system by optimizing industrial layout, enhancing innovation, and deepening international cooperation [1][2] - The Airport Economic Industrial Park has established five "park within park" carriers, focusing on industries such as aviation maintenance and manufacturing, and has attracted 350 enterprises with a total output value of 3.7 billion yuan by the end of 2024 [1][2] Group 2 - The Free Trade Blue Bay Industrial Park targets new material research, life sciences, and "airport services + digital economy," attracting major aviation companies and biomedical projects [2] - Both industrial parks are enhancing their industrial ecosystem by attracting over 50 related enterprises, forming a "vertical integration and horizontal diversification" development pattern [2] - The parks have established a "business demand response closed-loop" mechanism, providing services to enterprises and addressing their urgent needs, with 950 services and 417 issues resolved in 2024 [2] Group 3 - The parks are creating opportunities for local enterprises to expand internationally by hosting exchange salons and facilitating "going global" initiatives [3] - The Xi'an Airport New City is leveraging its unique advantages to build "going out" channels for enterprises, promoting technology exports to emerging markets [3] - The collaborative efforts of the two parks are aimed at strengthening the airport industry cluster and advancing towards becoming an "airport city" [3]